Latest news
Veliparib: Mechanism, Dose, Administration, And Clinical Trials - OncodailyOncodaily · Sun, 09 Aug 2026 10:16:14 GMTCNTX Hits Worst Day In History After Ovarian Cancer Trial Data — But Analysts See Buying Opportunity In Dip - StocktwitsStocktwits · Sat, 08 Aug 2026 02:45:54 GMTIMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 13:00:00 GMTOldham woman becomes world's first to receive new cancer therapy - BBCBBC · Thu, 30 Jul 2026 07:00:00 GMTFirst patient enrolled in GOG-3132/BEHOLD-Ovarian01 phase 3 study evaluating Mocertatug Rezetecan, a novel B7-H4–targeted ADC, in platinum-resistant ovarian cancer - EurekAlert!EurekAlert! · Mon, 27 Jul 2026 18:53:01 GMT